Yale Diagnostic Pathology Annual CME Review 2023: Featuring Genitourinary and Gynecologic Pathology Subspecialties

Significant advances in diagnostic pathology combined with molecular genetic discoveries have introduced reclassified disease entities and refined diagnostic criteria to guide clinical management of the patients and to provide clinicopathological framework for further investigation. In recognition of such rapid development, the World Health Organization (WHO) has been systemically updating its blue books in all areas of diagnostic pathology to serve as systemic educational tool for practicing pathologists to adopt new disease classification and related diagnostic criteria. The world-class Yale faculty are significant contributors to the WHO classifications in recent decade.

This two-day CME course is designed to provide an intense learning experience for pathologists at all career/expertise levels to maximize their diagnostic skills. While providing a comprehensive coverage, the course emphasizes knowledge gains in morphologic recognition and using ancillary studies in the most challenging areas of diagnostic genitourinary and gynecological pathology, particularly new disease classifications/diagnostic criteria.

LEARNING OBJECTIVES

• Gain competency in applying new diagnostic criteria and disease classifications.
• Gain competency in using ancillary studies to achieve accurate diagnosis.
• Become proficient in apply morphologic criteria in correlation with clinical findings for accurate pathology reporting.
• Learn strategies to avoid mismanagement and to enhance communication with clinical teams to ensure optimal patient care.

Accreditation Statement

Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Yale School of Medicine designates this Live Activity for a maximum of 12 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy

It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs. All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients) that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

Mitigation of Financial Relationships Statement

Yale CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible companies. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.